Innovate 32, a growth-oriented dental services organization, is proud to announce its partnership with Fort Bend Dental (“FBD”), a highly regarded provider of dental services in Houston, Texas.
Innovate 32 was formed by Shore Capital Partners, a Chicago-based private equity firm focused on lower-middle market investing. Under the leadership of Chief Executive Officer Josh Johnson and Innovate 32’s Board of Directors, Innovate 32 has continued to solidify new partnerships with leading dental practices throughout the South and Mid-Atlantic.
Founded in 1987, FBD provides a full suite of general and specialty dentistry services to patients in Southwest Houston. Since its founding, Dr. Dwight Peccora expanded the practice with four additional partners—Dr. Brian Machart, Dr. George Jabbour, Dr. Scott Pinkston, and Dr. Richard Baratta—who have decades of clinical experience providing quality care to their patients and scaling their practice locations to serve the unique needs of the community. “We are excited to join Innovate 32 to build the leading platform in dentistry and share its clear vision for doctor-led and doctor-invested partnerships. We look forward to leveraging Innovate 32’s business expertise and resources to enhance our services and better serve our patients and team,” said Dr. Peccora. Dr. Peccora will also be joining the Innovate 32 Board of Directors and will become the Chairman of the Innovate 32 Doctor Advisory Board.
The new partnership with FBD marks the next step in Innovate 32’s efforts to partner with growth-oriented dentists, share best practices, and deliver superior quality services. Innovate 32 now has a footprint in Texas, Tennessee, and Florida and seeks to form additional partnerships in those states.
“Partnering with Dr. Peccora, Dr. Machart, Dr. Jabbour, Dr. Pinkston, Dr. Baratta, and the Fort Bend Dental team expands our support of quality dental services to patients across Texas,” said Josh Johnson, CEO of Innovate 32. “Adding the experience of the doctors and their team to our organization aligns with our mission to be the partner of choice across Texas and beyond.”
The partnership represents an exciting chapter in the journey of both companies, with a shared mission to accelerate growth and lead through clinical excellence and patient satisfaction.
Fort Bend Dental was represented by Nate Thompson, Founder and CEO of Triumphant Transition Partners.
About Innovate 32
Innovate 32 is a Nashville-based dental services organization that supports a growing network of premier dental practices, delivering best-in-class patient experiences through unmatched partner support. Innovate 32 provides a firm foundation of essential management resources for its partners, empowering them to remain focused on what matters most—delivering the best patient care possible. Backed by Shore Capital, Innovate 32 is supported by a Board of Directors with deep experience in dentistry, operations, and private equity.
About Shore Capital Partners
Shore Capital, a Chicago-based private equity firm with offices in Nashville, is an investor in lower middle market companies in the healthcare, food and beverage, business services, industrial, and real estate industries. Shore’s strategy is to support management partners to grow faster with less risk through access to capital, world-class board and operational resources, and unmatched networking, development, and shared learnings across the portfolio. From 2020 to 2024, Shore received recognition from Inc. Magazine as a 5x Top Founder Friendly Investor and by Pitchbook Research for leading U.S. private equity deal volume for the past 10 years, from 2015 to 2024. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant potential to grow through industry consolidation and organic growth to generate value for shareholders. Shore has approximately $12.5 billion of assets under management and in additional investment platforms to which it provides business and operational consulting services.
Source: www.shorecp.com
News 31 January 2025
Innovate 32, a growth-oriented dental services organization, has announced its partnership with Bivens Dentistry (“BD”), a leading provider of dental services in Mt. Juliet, Tennessee.
Products 07 November 2024
Innovate 32 (“Innovate” or the “company”), a growth-oriented dental services organization, is proud to announce its partnership with Marion Dental Group (“MDG”), a leading provider of...
Products 26 July 2024
Shore Capital Partners (“Shore” or “Shore Capital”) is pleased to announce the founding of Innovate 32 (the “Company”) with the completion of a strategic partnership with Dr. Clint Newman...
News 07 September 2026
Integrated AEO and GEO strategies help dental practices remain visible as patients increasingly turn to AI tools and voice assistants for answers.
News 26 August 2026
Premier to broaden clinician access to Forward Science’s FDA-cleared, non-drug oral wound dressing for post-procedural periodontal care
USA 20 September 2026 - 30 November -0001
The American Academy of Implant Dentistry Annual Conference 2026 will take place from November 11, 2026 to November 14, 2026 in TBD, USA, offering dental professionals a focused environment for...
Editorials 20 September 2026
Dentistry33 survey shows small practices balancing growth, costs and technology modernization
Reader survey finds solo and small practices remain prominent while staffing, rising costs and digital adoption shape business priorities
Reader survey finds solo and small practices remain prominent while staffing, rising costs and digital adoption shape business priorities
Edra Professional Books 19 September 2026
Piezoelectric surgery of impacted teeth: A Practical Reference for Dental Professionals
Piezoelectric surgery of impacted teeth is an Edra professional dentistry reference focused on clinical practice, education and treatment planning.
Products 18 September 2026
Hard Tissue Charting and Natural Voice Perio Added to Overjet Voice
Providers talk through exams naturally while Overjet Voice handles hard tissue findings, perio measurements, and clinical notes directly in the PMS.
News 18 September 2026
Partnership leverages BioHorizons’ commercial network to broaden availability of Xtant’s allogeneic growth factor technology, OsteoFactor Pro™, which BioHorizons will private brand